Consortium Spotlight: Advancing Discoveries in Urea Cycle Disorders

The Urea Cycle Disorders Consortium (UCDC), now in its fourth cycle of funding, is one of the original Rare Diseases Clinical Research Network (RDCRN) consortia. When originally established, the UCDC had five sites; it is now an international network of 16 academic centers (13 in the US, one in Canada, and two in Europe) with 38 faculty investigators and 25 research staff members providing state-of-the-art care and conducting innovative clinical research in urea cycle disorders (UCD).

Read More

Early Investigator Spotlight: UCDC Trainees Drive Discoveries in Urea Cycle Disorders

The Urea Cycle Disorders Consortium (UCDC) is an original member of the Rare Diseases Clinical Research Network (RDCRN) family, having been part of the Network since its inception in 2003. Now in its 18th year, it is a leader among the consortia, having introduced a number of innovations in training and relationship to the pharmaceutical industry. Perhaps most importantly, the program has spawned a long list of independent academicians, five of whom are highlighted here.

Read More

Patient Spotlight: Mitchell Magyar Makes an Impact on Urea Cycle Disorder Research

Mitchell Magyar is a 13-year-old who loves golf, hiking, archery, riding his bike, and playing video games with his friends. He is also diagnosed with argininosuccinic aciduria (ASA), a type of urea cycle disorder. His mother Amy Magyar shares their journey with ASA, from diagnosis to getting involved with advocacy and research participation.

Read More